These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 10321575)

  • 1. Herpesviruses--a rationale for antiviral treatment in multiple sclerosis.
    Bergström T
    Antiviral Res; 1999 Feb; 41(1):1-19. PubMed ID: 10321575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valacyclovir].
    Biernat-Sudolska M
    Przegl Lek; 1998; 55(11):596-8. PubMed ID: 10216374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valacyclovir for the management of herpes viral infections.
    Chakrabarty A; Anderson NJ; Beutner R; Tyring SK
    Skin Therapy Lett; 2005 Feb; 10(1):1-4. PubMed ID: 15776202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML; Murray A; de Miranda P
    Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698
    [No Abstract]   [Full Text] [Related]  

  • 5. [Future prospects of valacyclovir in treating and preventing herpesviridae infections in immunosuppressed patients].
    Raffi F
    Presse Med; 1997 Jan; 26 Suppl 1():19-21. PubMed ID: 9082437
    [No Abstract]   [Full Text] [Related]  

  • 6. Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.
    Griffiths PD
    J Infect Dis; 2002 Oct; 186 Suppl 1():S131-7. PubMed ID: 12353198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric uses of valacyclovir, penciclovir and famciclovir.
    Dekker CL; Prober CG
    Pediatr Infect Dis J; 2001 Nov; 20(11):1079-81. PubMed ID: 11734715
    [No Abstract]   [Full Text] [Related]  

  • 8. Generic acyclovir vs. famciclovir and valacyclovir.
    Grose C; Wiedeman J
    Pediatr Infect Dis J; 1997 Sep; 16(9):838-41. PubMed ID: 9306476
    [No Abstract]   [Full Text] [Related]  

  • 9. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM; Faulds D
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
    Stein GE
    J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral agents in women's health: pharmacotherapeutics of treating influenza and herpes.
    Burpo RH
    J Midwifery Womens Health; 2002; 47(3):182-189. PubMed ID: 12071383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Several options for antiviral treatment trials in multiple sclerosis--but which targets should be selected?
    Bergström T
    Expert Opin Pharmacother; 2000 Sep; 1(6):1087-90. PubMed ID: 11249480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.
    Lycke J; Malmeström C; Ståhle L
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2438-41. PubMed ID: 12878501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valaciclovir (BW256U87): the L-valyl ester of acyclovir.
    Jacobson MA
    J Med Virol; 1993; Suppl 1():150-3. PubMed ID: 8245883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.
    Cattamanchi A; Saracino M; Selke S; Huang ML; Magaret A; Celum C; Corey L; Wald A; Casper C
    J Med Virol; 2011 Oct; 83(10):1696-703. PubMed ID: 21837785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valacyclovir.
    Acosta EP; Fletcher CV
    Ann Pharmacother; 1997 Feb; 31(2):185-91. PubMed ID: 9034421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of effects of famciclovir and valaciclovir on pathogenesis of herpes simplex virus type 2 in a murine infection model.
    Thackray AM; Field HJ
    Antimicrob Agents Chemother; 1996 Apr; 40(4):846-51. PubMed ID: 8849238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drugs for viruses other than human immunodeficiency virus.
    Razonable RR
    Mayo Clin Proc; 2011 Oct; 86(10):1009-26. PubMed ID: 21964179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses.
    Maxwell LK; Bentz BG; Gilliam LL; Ritchey JW; Pusterla N; Eberle R; Holbrook TC; McFarlane D; Rezabek GB; Meinkoth J; Whitfield C; Goad CL; Allen GP
    Am J Vet Res; 2017 Oct; 78(10):1126-1139. PubMed ID: 28945127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    Reusser P
    J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.